|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Towards development of enhanced fully-Lagrangian mesh-free computational methods for fluid-structure interaction显示文摘Simulation of incompressible fluid flow-elastic structure interactions is targeted by using fully-Lagrangian mesh-free computational methods. A projection-based fluid model(moving particle semi-implicit(MPS)) is coupled with either a Newtonian or a Hamiltonian Lagrangian structure model(MPS or HMPS) in a mathematically-physically consistent manner. The fluid model is founded on the solution of Navier-Stokes and continuity equations. The structure models are configured either in the framework of Newtonian mechanics on the basis of conservation of linear and angular momenta, or Hamiltonian mechanics on the basis of variational principle for incompressible elastodynamics. A set of enhanced schemes are incorporated for projection-based fluid model(Enhanced MPS), thus, the developed coupled solvers for fluid structure interaction(FSI) are referred to as Enhanced MPS-MPS and Enhanced MPS-HMPS. Besides, two smoothed particle hydrodynamics(SPH)-based FSI solvers, being developed by the authors, are considered and their potential applicability and comparable performance are briefly discussed in comparison with MPS-based FSI solvers. The SPH-based FSI solvers are established through coupling of projection-based incompressible SPH(ISPH) fluid model and SPH-based Newtonian/Hamiltonian structure models, leading to Enhanced ISPH-SPH and Enhanced ISPH-HSPH. A comparative study is carried out on the performances of the FSI solvers through a set of benchmark tests, including hydrostatic water column on an elastic plate,high speed impact of an elastic aluminum beam, hydroelastic slamming of a marine panel and dam break with elastic gate. | Abbas Khayyer Hitoshi Gotoh Hosein Falahaty Yuma Shimizu | 2018 | Journal of Hydrodynamics2018，30，1： | 8 |
| 2 | One-daily human Glp-1 analog liraglutide reduces systoic blood pressure-a meta analysis of six dinical trials(LEAD)显示文摘 | Fonseca V Madsbad S Falahati A | 2009 | Diabetes2009，58，1： | 1 |
| 3 | Assessment of left ventricular function using serum cardiac troponin I measurements following myocardial infarction显示文摘 | Apple FS Sharkey SW Falahati A | 1998 | Clin Chim Acta1998，272，： | 1 |
| 4 | Reliability assessment of smart grid considering direct cyber-power interdependencies显示文摘 | Falahati B Fu Y Wu L | 2012 | IEEE Trans on Smart Grid2012，3，3： | 1 |
| 5 | Implementation of serum cardiac troponin I as marker for detection of acute myocardial infarction显示文摘 | Falahati A Sharkey SW Christensen D | 1999 | Am Heart J1999，137，2： | 1 |
| 6 | Implementation of serum cardiac troponin I as marker for dedection of acute myocrodial infarction显示文摘 | Falahati A Sharkey SW Christensen D | 1999 | J Am Heart1999，137，2： | 1 |
| 7 | Plasminogen activator inhibitor-1 is reduced by the once-daily human glucagon-like peptide-1 analog liraglutide when used in the treatment of type 2 diabetes显示文摘 | Plutzky J Poulter NR Falahati A | 2009 | Circulation2009，120，2： | 1 |
| 8 | Once-daily human GLP-1 analog liraglutide reduces systolic blood pressure-a-meta-analysis of six clinical trials(LEAD)显示文摘 | Fonseca V Madsbad S Falahati A | 2009 | Diabetes2009，58，1： | 1 |
| 9 | Power-efficient prefetching on GPGPUs显示文摘 | FALAHATI H HESSABI S ABDI M | 2014 | The Journal of Supercomputing2014，，： | 1 |
| 10 | Assessment of left ventricular function using serum cardiac troponin I measurements following myocardial infarction 显示文摘 | Sharkey SW Falahati A | 1998 | Clin Chim Acta1998，272，： | 1 |
| 11 | Stereoselective synthesis and antifungal activity of (Z)-trans-3-azoly1-2-methyl chromanone oxime ethers显示文摘 | Emami S Falahati M Banifatemi A | 2004 | Bioorg& &led Chem2004，12，： | 1 |
| 12 | Implementation serum cardiac troponin I as the marker for detection of acute myocardial infarction 显示文摘 | Falahati A Sharkey SW Christensen D | 1998 | Am Heart J1998，135，： | 1 |
| 13 | Cardiac troponin I and creatine kinase-MB mass to rule out myocardial injury in hospitalized patients with renal insufficiency显示文摘 | Mc Laurin MD Apple FS Falahati A | 1998 | Am J Cardiol1998，82，： | 1 |
| 14 | Implementation serum cardiac troponin I as the marker for detection of acute myocardial infarction显示文摘 | Falahati A Sharkey SW Christensen D | 1998 | Am Heart J1998，135，： | 1 |
| 15 | Mild renal impairment has no effect on the efficacy and safety of Liraglutide 显示文摘 | Davidson J A Brett J Falahati A | 2010 | Endocr Pract2010，6，： | 1 |
| 16 | Liraglutide improves glycemic control significantly more than glimepiride in patients with higher baseline beta-cell funetion显示文摘 | Matthews DR Falahati A Tort AD | 2009 | Diabetes2009，58，： | 1 |
| 17 | CALPHAD modeling of metastable phases in the A1-Mg-Si system 显示文摘 | POVODEN-KARADENIZ E LANG P WARCZOK P FALAHATI A WUJUN KOZESCHNIK E | 2013 | Calphad2013，43，： | 1 |
| 18 | Adding liraglutide to existing therapy rather than substituting it for existing therapy produees greater improvement in glycemic control: evidence from a meta-analusis 显示文摘 | Nauck MA Pratley RE Falahati A | 2009 | Diabetes2009，58，： | 1 |
| 19 | Ischemia-indnced neu- roinflammation is associated with disrupted development of oligo- dendrocyte progenitors in a model of periventricular leukomalacia 显示文摘 | Falahati S Breu M Waickman A T | 2013 | Dev Neurosci2013，35，23： | 1 |
| 20 | A once-daily human GLP-1analog liraglutide reduces systolic blood pressure-a meta analysis of six clinical trials(LEAD)显示文摘 | Fonsoca V Falahati A Zychma M | 2009 | Diabetes2009，52，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员